Log in
Enquire now
PhaseV

PhaseV

PhaseV is leveraging cutting-edge algorithms such as reinforcement learning and causal ML for adaptive trial design and closed-loop execution, in order to improve trial success rate while maximizing resource and time efficiency.

OverviewStructured DataIssuesContributors

Contents

phasevtrials.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Artificial Intelligence (AI)
Artificial Intelligence (AI)
Health technology
Health technology
‌
Data Analytics
Biotechnology
Biotechnology
Pharmaceutical industry
Pharmaceutical industry
Location
Boston, Massachusetts, United States
Boston, Massachusetts, United States
B2X
B2B
B2B
CEO
‌
Raviv Pryluk
Founder
‌
Raviv Pryluk
Number of Employees (Ranges)
11 – 50
Email Address
info@phasevtrials.com
Investors
Exor (company)
Exor (company)
Accel
Accel
LionBird
LionBird
Total Funding Amount (USD)
50,000,000
Latest Funding Round Date
May 13, 2025
CTO
‌
Elad Berkman
Latest Funding Type
Series A
Series A

Other attributes

Latest Funding Round Amount (USD)
50,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like PhaseV

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.